Chiron DepoCyt
Executive Summary
Manufacturing difficulties that have halted distribution of intrathecal lymphomatous meningitis treatment should be resolved "shortly," company tells May 3 earnings conference call. Chiron has not been shipping DepoCyt due to stability problems at SkyePharma's San Diego plant, where the product is manufactured. DepoCyt was the subject of a Class III recall Dec. 29 due to failure of six-month stability testing